Product Information
HEPARIN SODIUM 5,000 UNIT/ML VIAL is a generic product labeled by Sagent Pharmaceuticals, priced at $1.2441 per ML under NDC 25021040266. Its NADAC has been published 322 times since Jan 23, 2019.
FDA first approved this application on Jun 30, 2010. Its Orange Book therapeutic-equivalence code is AP.
Strength
5000 [USP'U]/mL
Manufacturer
Sagent PharmaceuticalsNDC
25021040266
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS; SUBCUTANEOUS
Effective Date
11/18/2026
Active Ingredients
HEPARIN SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA090808FDA Approved
6/30/2010
TE Code
AP
On Market Since
7/6/2010
Pharmacological Classes
Price Statistics
The NADAC for HEPARIN SODIUM 5,000 UNIT/ML VIAL has been published 322 times since Jan 23, 2019, and over the history we have for it it has declined 8.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2441 per ML |
|---|---|
| All-time high | $2.3571 (Oct 13, 2021) |
| All-time low | $1.0430 (Nov 19, 2025) |
| 52-week high | $1.2441 |
| 52-week low | $1.0430 |
| Median price | $1.3577 |
| Average price | $1.4449 |
| Largest weekly change | +29.0% (Apr 21, 2021) |
| Weeks tracked | 322 |
| Tracking since | Jan 23, 2019 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sagent Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Heparin Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anti-coagulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HEPARIN SODIUM 5,000 UNIT/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for HEPARIN SODIUM 5,000 UNIT/ML VIAL, manufactured by Sagent Pharmaceuticals, is $1.2441 per ML (NDC 25021040266), effective Nov 18, 2026.
How has the price of HEPARIN SODIUM 5,000 UNIT/ML VIAL changed over time?
Over the history we have for it, the NADAC for HEPARIN SODIUM 5,000 UNIT/ML VIAL has declined 8.4%. It has been tracked across 322 weekly CMS publications since Jan 23, 2019.
What are the highest and lowest recorded NADAC prices for HEPARIN SODIUM 5,000 UNIT/ML VIAL?
Since Jan 23, 2019, the NADAC for HEPARIN SODIUM 5,000 UNIT/ML VIAL has ranged from a low of $1.0430 (Nov 19, 2025) to a high of $2.3571 (Oct 13, 2021), with a median of $1.3577 per ML.
Are there cheaper alternatives to HEPARIN SODIUM 5,000 UNIT/ML VIAL?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HEPARIN SODIUM 5,000 UNIT/ML VIAL, is $1.2024 per ML — about 3% below HEPARIN SODIUM 5,000 UNIT/ML VIAL.
Who manufactures HEPARIN SODIUM 5,000 UNIT/ML VIAL?
HEPARIN SODIUM 5,000 UNIT/ML VIAL (NDC 25021040266) is labeled by Sagent Pharmaceuticals, and CMS classifies it as a generic product.